OVID

Conviction 70HealthcareScan · Mon, Aug 10, 2026

OVID$2.62-0.38%

ResistanceSupportVol 14

Vol MA14 2.51M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Ovid Therapeutics Inc.PHARMACEUTICAL PREPARATIONSwww.ovidrx.com ↗

Price2.62

Change-0.38%

Gap-2.66%

Rel volume9.68×

Avg volume2.16M

Avg $ vol5.38M

SMA 202.43

SMA 502.46

SMA 2002.06

Price vs 50+6.54%

Price vs 200+26.97%

MA stackbullish

50/200 cross—

Supertrendup · 2.19

RSI (14)58

MACD hist0.04

MACD crossbull · 4d

Stoch %K / %D86 / 89

ADX (14)14

+DI / −DI22 / 15

RSI divergenceBearish

MACD divergenceBullish

ATR %+5.77%

ADR %5.82%

52w high2.96

52w low0.5149

From 52w high-11.49%

Above 52w low+408.84%

New 52w highNo

SqueezeOff

Bollinger width19.99%

%B0.89

Donchian pos85.71%

Donchian high2.69

Donchian low2.20

AVWAP (52w high)2.58

vs AVWAP high+1.67%

AVWAP (52w low)2.02

vs AVWAP low+29.42%

OBV trendFlat

Chaikin MF (20)0.48

Today vs 20d9.68×

Avg vol (14d)2.51M

Avg vol (20d)2.16M

Avg $ vol (20d)5.38M

Market cap489M

RS 3m (vs SPY)-9.36%

RS 6m (vs SPY)+67.27%

RS line new highNo

Trend template7/8

Technical rank84.1

1 week+12.45%

1 month+3.97%

3 months-6.43%

6 months+63.75%

1 year+412.22%

YTD+48.86%

P/E-28.08

P/B2.47

P/S67.43

P/FCF-12.76

EPS-0.7400

Div yield—

ROE-8.78%

ROA-7.72%

Debt/Eq—

Current10.17

EV/EBITDA-9.37

Gross margin—

Net margin-240.13%

Rev growth1181.27%

EPS growth34.12%

Price target6.17

Target upside135.50%

Analyst ratingBuy

Institutional66.89%

Ent. value394.93M

Revenue0

Net income-16.99M

Gross profit—

Free cash flow-38.33M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out186.64M

Employees23

ListedFri, May 5, 2017

Free float97.68M

Float %75.0%

Short interest22.04M

Days to cover12.7d

Short volume57.5%

Squeeze score92 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.12 vs −$0.12

Last surprise0.0% beat

Setup gradeB

Conviction70 / 100

Pattern quality—

Tech rank84.1 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.83

Support2.20

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in OVID

All disclosures →

No recent disclosed trades by Congress in OVID. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in OVID · 4 buys

Insider	Side	Shares	Value	Traded	Filed
Carter Charles Ross Chief Financial Officer · Common Stock · 2026-07-06	Grant	50K	—	2026-07-06	2026-07-08
Fitzgerald Kevin Joseph Director · Common Stock · 2026-04-07	Grant	17.58K	$45K	2026-04-07	2026-04-09
PAPADOPOULOS STELIOS Director · Common Stock · 2026-04-07	Grant	17.58K	$45K	2026-04-07	2026-04-09
Friedman Bart Director · Common Stock · 2026-04-07	Grant	8.79K	$22K	2026-04-07	2026-04-09

SEC filings

EDGAR filings in OVID · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.